Investigation of the 1H NMR visibility of lactate in different rat and human brain cells

In recent years, 1H MRS has been used in a number of studies to measure the lactate content of brain, and it is generally assumed that the methyl resonance at 1.3 ppm reflects the total amount of lactate present in the tissue. However, reduced NMR visibility of lactate has recently been reported for blood, heart and skeletal muscle as well as for bacteria. We have assessed the NMR visibility of lactate in cultures of human and rat brain cells, comparing the concentrations measured by NMR and by biochemical methods. Contributions of fatty acids have been eliminated using their different relaxation behavior. We found approximately 30% of the lactate to be undetectable by NMR in the studied cell cultures. While the mechanism partially masking lactate in 1H spectra is not yet understood, the potential invisibility of some pools of lactate to NMR may greatly affect the interpretation of brain spectra.

[1]  A Haase,et al.  High‐resolution one‐and two‐dimensional 1H MRS of human brain tumor and normal glial cells , 1994, NMR in biomedicine.

[2]  W. Heindel,et al.  Lactate imaging of the human brain at 1.5 T using a double‐quantum filter , 1993, Magnetic resonance in medicine.

[3]  George Fein,et al.  Proton magnetic resonance spectroscopy of human brain: Applications to normal white matter, chronic infarction, and MRI white matter signal hyperintensities , 1992, Magnetic resonance in medicine.

[4]  M. Bendall,et al.  Selective intracellular lactate invisibility in Enterococcus faecalis , 1992, Magnetic resonance in medicine.

[5]  C T Moonen,et al.  On the precision of diffusion/perfusion imaging by gradient sensitization , 1992, Magnetic resonance in medicine.

[6]  J. Medina,et al.  Lactate Utilization by Isolated Cells from Early Neonatal Rat Brain , 1991, Journal of neurochemistry.

[7]  R. Shulman,et al.  Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[8]  R. Deslauriers,et al.  Preservation of high-energy phosphates in human myocardium. A phosphorus 31-nuclear magnetic resonance study of the effect of temperature on atrial appendages. , 1989, The Journal of thoracic and cardiovascular surgery.

[9]  J. Frahm,et al.  Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. , 1989, Radiology.

[10]  J. Frahm,et al.  Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites , 1989, Magnetic resonance in medicine.

[11]  M. Irving,et al.  The 1H NMR visibility of intracellular lactate in Streptococcus faecalis , 1989, NMR in biomedicine.

[12]  J. W. B. van der Sprenkel,et al.  1H and 31P NMR measurement of cerebral lactate, high‐energy phosphate levels, and pH in humans during voluntary hyperventilation: associated EEG, capnographic, and doppler findings , 1989, Magnetic resonance in medicine.

[13]  P. V. van Rijen,et al.  Cerebral lactate detected by regional proton magnetic resonance spectroscopy in a patient with cerebral infarction. , 1988, Stroke.

[14]  Jimmy D Bell,et al.  NMR‐invisible lactate in blood plasma , 1988, FEBS letters.

[15]  D. Gadian,et al.  Quantitative estimation of lactate in the brain by 1H NMR , 1988, Magnetic resonance in medicine.

[16]  R G Shulman,et al.  Spatially localized 1H NMR spectra of metabolites in the human brain. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[17]  M. Décorps,et al.  Spectral editing in Vivo by homonuclear polarization transfer , 1987 .

[18]  P. Belton,et al.  Quantitative proton magnetic resonance of plasma from uraemic patients during dialysis , 1987 .

[19]  T. L. James,et al.  Comparison of lactate concentration determinations in ischemic and hypoxic rat brains by in vivo and in vitro 1H NMR spectroscopy , 1987, Magnetic resonance in medicine.

[20]  U. Bogdahn,et al.  Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours. , 1987, British Journal of Cancer.

[21]  M. Kienlin,et al.  Use of rotating-phase DANTE pulses for in vivo proton NMR spectral editing with a single irradiation facility , 1987 .

[22]  W. Paschen,et al.  Lactate and pH in the Brain: Association and Dissociation in Different Pathophysiological States , 1987, Journal of neurochemistry.

[23]  D. Gadian,et al.  Proton NMR studies of muscle metabolites in vivo , 1985 .

[24]  R G Shulman,et al.  Homonuclear 1H double-resonance difference spectroscopy of the rat brain in vivo. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[25]  A. Hansen,et al.  Extracellular pH Changes during Spreading Depression and Cerebral Ischemia: Mechanisms of Brain pH Regulation , 1984, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[26]  P. J. Hore,et al.  Solvent suppression in Fourier transform nuclear magnetic resonance , 1983 .

[27]  B. Hamprecht,et al.  High activity of choline acetyltransferase induced in neuroblastoma x glia hybrid cells. , 1974, Experimental cell research.

[28]  B. Siesjö,et al.  The effect of bilateral carotid artery ligation upon the blood flow and the energy state of the rat brain. , 1972, Acta physiologica Scandinavica.

[29]  S. Mukerji,et al.  Simulation of aspects of ischemia in cell culture: Changes in lactate compartmentation , 1990, Glia.

[30]  B. Hamprecht,et al.  Primary glial cultures as a model for studying hormone action. , 1985, Methods in enzymology.